Loading...
A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
BACKGROUND: Iron deficiency (ID) is common in patients with chronic kidney disease (CKD). Intravenous (IV) iron in heart failure leads to improvement in exercise capacity and improvement in quality-of-life measurements; however, data in patients with CKD are lacking. METHODS: The Iron and the Heart...
Na minha lista:
| Udgivet i: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010943/ https://ncbi.nlm.nih.gov/pubmed/33784968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02308-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|